Tag: European Lobular Breast Cancer Consortium

ILC overlooked in Breast Cancer Clinical Trials

Invasive Lobular Breast Cancer, an overlooked Subtype in Clinical Trials was one of the Poster Presentations at ESMO Breast Cancer Conference in Berlin last week. Lobular Ireland are very proud to be co authors on this piece of work led by Karen Van Baelen as Researcher from the European Lobular Breast Cancer Consortium from Leuven.…

Day 25 #LivingWithLobular

Dear Lobular cancer friends, I am glad to be able to share my story with you all. My name Michelle Bonner and I live in Co. Donegal.  I found a sizeable area like two adjacent cyst type lumps on my upper right breast in December 2020, I went to my GP in January and was…

Invasive Lobular Breast Cancer requires different Clinical Management to Invasive Ductal Cancer

This week The Royal College of Surgeons hosted The Breast Cancer Ireland Dublin Steroid Cancer Conference. This prestigious event featuring presentations from world leaders in Oncology drew lots of media attention and was extremely well attended. On Thursday 20th October a Lobular Breast Cancer Session was introduced and moderated by Professor William Gallagher, deputy director…

Day 17 #LivingWithLobular

Lobular Ireland set themselves a task this October to raise awareness of Invasive Lobular Cancer in Ireland. In doing so they will share Patient Stories and insights as to how Lobular Breast Cancer is different. Most women in our group agree that Lobular is #NotAlwaysALump, almost all agree that it didn’t show up on their…

Watch ” Elbcc/ILC Symposium 2022. KeyNote Address

#Livingwithlobular Day #9 October 2022 As we approach week 2 of our October 2022 Awareness and Education Campaign we’re sharing a link above from the ELBCC.ORG Symposium in Utrecht Listen to Professor Steffi Oesterrich deliver the 1st Keynote Address beginning with “A Letter from Leigh Pate’ who was unable to travel to be with us.…

Day 8 #LivingWithLobular

Our #Lobular Breast Cancer Awareness campaign contines into week #2 with the full knowledge that our #European ILC Research Partners have our backs. It is only with Lobular Specific Research that Patients with Invasive Lobular Carcinoma can be secure in the knowledge that their Subtype of Breast Disease will be treated as it should be.…

Day 7 #LivingWithLobular

Who we are and why we’re here Lobular Ireland was born in 2019. It was established out of a recognised need to create a space for ILC Patients, (especially those diagnosed in Ireland) to be able to access evidence based information, specific to Lobular breast cancer and to enhance a greater understanding of this lesser…

Lobular Breast Cancer in Focus

Join us on Thursday 18th August for this event in the Royal College of Surgeons RCSI 26 York Streethttps://maps.app.goo.gl/Wd3nDzrPMGhsTShw8 Lobular Ireland are delighted to have organised this, with amazing support from Precision Oncology Ireland and Dr Elspeth Ward Professor Darren O’Connor and Dr Damir Vareslija from the Royal College of Surgeons, with support from The…

Patient Advocacy Champion Award for Lobular Ireland

The Irish Cancer Society are delighted to announce that it has awarded Siobhán Freeney Round 1 of the Patient Advocate in Cancer Research Champion Awardees 2022. Siobhán Freeney http://www.LobularIreland.com is a patient advocate for Lobular Breast Cancer Research. After her delayed, late stage Invasive lobular breast cancer diagnosis, Siobhán found it incredibly difficult to find relevant…

All About Lobular in Utrecht June 20 – 22

The City of Utrecht and The European Lobular Breast Cancer Consortium will play host to the 2022 International ELBCC Lobsterpot Lobular Breast Cancer Symposium and Summerschool Full Agenda can be found at this link https://ilcsymposium2022.com/ There will be a two hour Patient Advocate led Session on Tuesday 21st where we look forward to meeting, many…